- 专利标题: METHOD FOR DIAGNOSING CANCER AND PREDICTING CANCER TYPE BY USING TERMINAL SEQUENCE MOTIF FREQUENCY AND SIZE OF CELL-FREE NUCLEIC ACID FRAGMENT
-
申请号: EP22811704.0申请日: 2022-05-30
-
公开(公告)号: EP4350708A1公开(公告)日: 2024-04-10
- 发明人: CHO, Eun Hae , LEE, Tae-Rim , PARK, Sook Ryun
- 申请人: GC Genome Corporation
- 申请人地址: KR Yongin-si, Gyeonggi-do 16924 107, Ihyeon-ro 30beon-gil, Giheung-gu
- 代理机构: Mewburn Ellis LLP
- 优先权: KR20210068891 20210528
- 国际公布: WO2022250513 20221201
- 主分类号: G16H50/20
- IPC分类号: G16H50/20 ; G16H50/50 ; G16B30/10 ; G16B40/20 ; G16H30/40 ; G06N3/08 ; G06N3/04
摘要:
Disclosed is a method for diagnosing cancer and predicting a cancer type using fragment end motif frequencies and sizes of cell-free nucleic acid, and more preferably, to a method for diagnosing cancer and predicting a cancer type by extracting nucleic acids from a biological sample to obtain sequence information, acquiring fragment end motif frequencies and sizes of nucleic acids based on the aligned reads, converting the fragment end motif frequencies and sizes of nucleic acids into vectorized data, inputting the vectorized data to a trained artificial intelligence model and analyzing a resulting calculated value. The method includes generating vectorized data and analyzing the same using an AI algorithm and thus is useful due to high sensitivity and accuracy thereof even in the case of low read coverage.
信息查询